Insightful & Extensive

PGx | Pharmacogenomics

Pharmacogenomics Testing (PGx) is an innovative approach to prescriptive medicine that allows physicians to best understand how patients will respond to certain medications based on their specific DNA profile which influences Pharmacokinetics (PK) and Pharmacodynamics (PD).

Pharmacokinetics (PK) is the movement of drugs through the body, while Pharmacodynamics(PD) is the body’s biological response to those drugs. More specifically, PK describes a drug’s absorption, distribution, metabolism, and excretion, and PD describes how biological processes in the body respond to or are impacted by a drug. Most simply, Pharmacokinetics (PK) is what the body does to the drug and Pharmacodynamics (PD) is what the drug does to the body.

The progressive benefits of Pharmacogenomics (PGx) Testing vastly improve patient care by personalizing prescribed medications through evidence-based drug and dose selection. Additionally, personalizing prescribed medications will reduce adverse drug events and treatment failures, decrease side effects and non-adherence from trial-and-error prescribing, and decrease patient costs from unnecessary physician appointments and ineffective prescription trials.

Pharmacogenomics Testing (PGx) is transforming preventative medicine by applying the insight of a patient’s DNA profile to personalize prescriptive medication for the most effective treatment plan available.